XML 19 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statement of Stockholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Common Stock [Member]
Capital in Excess of Par Value [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Loss [Member]
Noncontrolling Interests [Member]
Beginning balance at Dec. 31, 2021 $ 8,560.1 $ 208.5 $ 6,143.7 $ 2,882.3 $ (726.1) $ 51.7
Beginning balance (in shares) at Dec. 31, 2021   208.5        
Net earnings 1,116.0     1,114.2   1.8
Net purchase of subsidiary shares from noncontrolling interests (3.2)         (3.2)
Dividends paid to noncontrolling interests (3.5)         (3.5)
Net change in pension asset/liability, net of taxes (12.3)       (12.3)  
Foreign currency translation (512.0)       (511.8) (0.2)
Change in fair value of derivative instruments, net of taxes 109.8       109.8  
Compensation expense related to stock option plan grants 27.9   27.9      
Common stock issued in: purchase transactions 165.5 $ 0.9 164.6      
Common stock issued in: purchase transactions (in shares)   0.9        
Stock option plans 76.1 $ 1.4 74.7      
Stock option plans (in shares)   1.4        
Employee stock purchase plan 47.6 $ 0.3 47.3      
Employee stock purchase plan (in shares)   0.3        
Shares issued to benefit plans 74.4 $ 0.5 73.9      
Shares issued to benefit plans (in shares)   0.5        
Deferred compensation and restricted stock (21.9) $ 0.3 (22.2)      
Deferred compensation and restricted (in shares)   0.3        
Cash dividends declared on common stock (434.3)     (434.3)    
Ending balance at Dec. 31, 2022 9,190.2 $ 211.9 6,509.9 3,562.2 (1,140.4) 46.6
Ending balance (in shares) at Dec. 31, 2022   211.9        
Net earnings 966.0     969.5   (3.5)
Net purchase of subsidiary shares from noncontrolling interests (3.1)         (3.1)
Dividends paid to noncontrolling interests (1.0)         (1.0)
Net change in pension asset/liability, net of taxes 12.3       12.3  
Foreign currency translation 258.8       257.8 1.0
Change in fair value of derivative instruments, net of taxes 78.2       78.2  
Compensation expense related to stock option plan grants 33.5   33.5      
Common stock issued in: purchase transactions 525.8 $ 2.5 523.3      
Common stock issued in: purchase transactions (in shares)   2.5        
Stock option plans $ 65.2 $ 1.2 64.0      
Stock option plans (in shares) 1.3 1.2        
Employee stock purchase plan $ 55.0 $ 0.3 54.7      
Employee stock purchase plan (in shares)   0.3        
Shares issued to benefit plans 84.6 $ 0.4 84.2      
Shares issued to benefit plans (in shares)   0.4        
Deferred compensation and restricted stock 28.6 $ 0.4 28.2      
Deferred compensation and restricted (in shares)   0.4        
Cash dividends declared on common stock (478.8)     (478.8)    
Ending balance at Dec. 31, 2023 $ 10,815.3 $ 216.7 7,297.8 4,052.9 (792.1) 40.0
Ending balance (in shares) at Dec. 31, 2023 216.7 216.7        
Net earnings $ 1,470.4     1,462.7   7.7
Net purchase of subsidiary shares from noncontrolling interests (17.9)         (17.9)
Dividends paid to noncontrolling interests (3.8)         (3.8)
Net change in pension asset/liability, net of taxes 13.9       13.9  
Foreign currency translation (365.3)       (365.4) 0.1
Change in fair value of derivative instruments, net of taxes (7.5)       (7.5)  
Compensation expense related to stock option plan grants 47.8   47.8      
Common stock issued in: purchase transactions 140.8 $ 0.6 140.2      
Common stock issued in: purchase transactions (in shares)   0.6        
Stock option plans $ 92.7 $ 1.3 91.4      
Stock option plans (in shares) 1.4 1.3        
Employee stock purchase plan $ 69.8 $ 0.3 69.5      
Employee stock purchase plan (in shares)   0.3        
Shares issued to benefit plans 98.5 $ 0.4 98.1      
Shares issued to benefit plans (in shares)   0.4        
Deferred compensation and restricted stock 10.4 $ 0.3 10.1      
Deferred compensation and restricted (in shares)   0.3        
Stock issuance from public offering 8,344.4 $ 30.4 8,314.0      
Stock issuance from public offering (in shares)   30.4        
Cash dividends declared on common stock (529.9)     (529.9)    
Ending balance at Dec. 31, 2024 $ 20,179.6 $ 250.0 $ 16,068.9 $ 4,985.7 $ (1,151.1) $ 26.1
Ending balance (in shares) at Dec. 31, 2024 250.0 250.0